Literature DB >> 11020911

Clinicopathologic differences between early gastric remnant cancer and early primary gastric cancer in the upper third of the stomach.

T Imada1, Y Rino, S Hatori, M Shiozawa, M Takahashi, T Amano, J Kondo, O Kobayashi, M Sairenji, H Motohashi.   

Abstract

BACKGROUND/AIMS: This study was designed to clarify the clinicopathologic characteristics and survival in early gastric remnant cancer and compare with early primary cancer in the upper third of the stomach.
METHODOLOGY: Twenty-five patients with early gastric remnant cancer, who underwent resection at Kanagawa Cancer Center and First Department of Surgery, Yokohama City University between 1974 and 1996 were evaluated in this study. Various clinicopathologic characteristics, such as age, sex, symptoms, size of tumor, depth of invasion, lymph node metastasis, cell differentiation, and survival were investigated and early gastric remnant cancer was compared with early primary cancer in the upper third of the stomach.
RESULTS: According to the macroscopic type, protruded type such as I or II type accounted for a great majority in early gastric remnant cancer, while II c depressed type was common in early primary cancer in the upper third of the stomach, comprising 64.2% of all cases. Pathological examination disclosed that well-differentiated carcinoma and mucosal carcinoma were more frequently observed in early gastric remnant cancer than in early primary cancer in the upper-third of the stomach. The 5-year survival rate was 83.5% for early primary cancer in the upper-third of the stomach. In contrast, no patients experienced recurrence after operation for early gastric remnant cancer.
CONCLUSIONS: From the view point of clinicopathological evaluation, gastric remnant cancer is a special from of gastric cancer. A follow-up program is important in order to detect early gastric remnant cancer. A low incidence of lymph node metastasis suggests that endoscopic mucosal resection of the tumor or limited operation could be performed under strict indication.

Entities:  

Mesh:

Year:  2000        PMID: 11020911

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach.

Authors:  Shinsaku Honda; Etsuro Bando; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Taiichi Kawamura; Teiichi Sugiura; Yusuke Kinugasa; Katsuhiko Uesaka; Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-09-16       Impact factor: 7.370

2.  Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy.

Authors:  Jong Yeul Lee; Il Ju Choi; Soo-Jeong Cho; Chan Gyoo Kim; Myeong-Cherl Kook; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim
Journal:  Surg Endosc       Date:  2009-12-09       Impact factor: 4.584

3.  Surgical treatment and prognosis of esophageal cancer after distal gastrectomy.

Authors:  Lihui Wu; Zhifei Xu; Xuewei Zhao; Jianqiu Li; Yaochang Sun
Journal:  J Gastrointest Surg       Date:  2009-09-15       Impact factor: 3.452

4.  Survival and surgical outcomes of cardiac cancer of the remnant stomach in comparison with primary cardiac cancer.

Authors:  Yi Wang; Chang-Ming Huang; Jia-Bin Wang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jian-Xian Lin; Jun Lu
Journal:  World J Surg Oncol       Date:  2014-01-27       Impact factor: 2.754

5.  Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study.

Authors:  Qi-Yue Chen; Qing Zhong; Jun-Feng Zhou; Xian-Tu Qiu; Xue-Yi Dang; Li-Sheng Cai; Guo-Qiang Su; Dong-Bo Xu; Guang-Tan Lin; Kai-Qing Guo; Zhi-Yu Liu; Qiu-Xian Chen; Ping Li; Teng-Wen Li; Jian-Wei Xie; Shuang-Ming Lin; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Chao-Hui Zheng; Wei Lin; Qing-Liang He; Chang-Ming Huang
Journal:  Cancer Sci       Date:  2019-12-26       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.